88IV - PR Newswire Asia's news


Global First \| NMPA Accepts IND Application for Mabwell's Innovative LILRB4/CD3 TCE Bispecific Antibody 6MW5311 SHANGHAI , April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Administration ... 2026-04-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab) SHANGHAI , April 16, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with a full industry chain, announced that the National Medical Products Administration (NMPA) has ... 2026-04-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Clicklinks \| 14-Day Candidate Antibody Discovery - Sanyou AI-STAL 2.0 Defines the Era of Ultimate Speed in Drug Molecule Discovery SHANGHAI , April 15, 2026 /PRNewswire/ -- ... 2026-04-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tsingke Unveils 'Zero-Contact' Gene Synthesis to Safeguard Core Genetic Sequences BEIJING , April 15, 2026 /PRNewswire/ -- As the pace of biotechnology research accelerates, companies are increasingly challenged to balance rapid innovation with the protection of sensitive genetic ... 2026-04-15T Biotechnology Computer/Electronics Health Care/Hospital High Tech Security
Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform SYDNEY , April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the ... 2026-04-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Taiho Ventures, LLC Celebrates 10th Anniversary TOKYO and MENLO PARK, Calif. , April 15, 2026 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) and Taiho Ventures, LLC (TVL), a strategic corporate venture capital (CVC) arm of Taiho ... 2026-04-15T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
RIMAN's Parent Company Announces Sponsored Research Agreement to Advance Araliadiol Using Organ-on-a-Chip Technology SEOUL, South Korea , April 15, 2026 /PRNewswire/ -- ASK Company, the parent company of RIMAN, has entered into a sponsored research agreement with Mitragotri Laboratory at the Harvard John A. Paulson ... 2026-04-15T Biotechnology Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing Company is among the first in China's drug-device combination products sector to obtain this certification, delivering superior solutions to global clients Zero non-conformities demonstrates company's ... 2026-04-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial SHANGHAI , April 15, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18 F-FD4 (R&D code: SST001), ... 2026-04-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Advances in Parkinson's Disease Cell Therapy: XellSmart Launches a Multicenter Phase II Clinical Trial Following Encouraging Phase I Results SUZHOU, China , April 14, 2026 /PRNewswire/ -- In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology